News

Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease…
Read More...

LakePharma, the leading US-based biologics company specializing in antibody and protein engineering, cell line development, and protein production, announced that it has successfully…
Read More...

Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing a first-in-class platform of novel therapeutic compounds for the treatment of diseases…
Read More...

Biopharmaceutical company Emalex Biosciences (Emalex), the newest member of the Paragon Biosciences (Paragon) portfolio of companies, today announced it acquired Psyadon Pharmaceuticals…
Read More...

Izana Bioscience announced the initiation of a phase II proof-of-concept clinical study of namilumab in ankylosing spondylitis, a debilitating arthritic disease of the spine that…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Xolair (omalizumab) for the prevention of severe allergic reactions…
Read More...

Global contract packaging organisation (CPO), Tjoapack has launched a new postponement packaging service to help customers address supply chain challenges including variable demand and…
Read More...

Cancer Prevention Pharmaceuticals announced the signing of a license agreement with Mallinckrodt Pharmaceuticals, through its Sucampo AG subsidiary, wherein Mallinckrodt obtained…
Read More...

Medicure Inc. announced that the United States Food and Drug Administration has approved its Abbreviated New Drug Application for Sodium Nitroprusside Injection 50 mg/2 mL (25 mg/mL)…
Read More...

TraceLink Inc., announced its Russia compliance solution, providing companies with the ability to meet requirements for serialization, traceability, and compliance reporting for all…
Read More...

Astellas Pharma Inc. and Quethera Limited announced that Astellas has acquired Quethera, a gene therapy company headquartered in the United Kingdom, that is focused on developing novel…
Read More...

Teneobio and Poseida Therapeutics announced a new research collaboration and licensing agreement to develop novel CAR-T therapies using Teneobio’s heavy chain only domain antibodies…
Read More...

Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, and Elasmogen, an SME focused on the development…
Read More...

PaxVax announced that it has entered into a definitive agreement to be acquired by Emergent BioSolutions. PaxVax is majority owned by an affiliate of Cerberus Capital Management, a…
Read More...

Perrigo Company plc announced that its Board of Directors approved a plan to separate the Company's Prescription Pharmaceuticals (Rx) business following the Company's previously…
Read More...

The U.S. Food and Drug Administration issued new scientific recommendations aimed at encouraging more widespread innovation and development of novel medication-assisted treatment (MAT)…
Read More...

Regeneron Pharmaceuticals, Inc. and bluebird bio, Inc. announced a collaboration to apply their respective technology platforms to the discovery, development and commercialization of…
Read More...

Seattle Children’s has opened a chimeric antigen receptor (CAR) T-cell immunotherapy trial for children and young adults with relapsed or refractory non-central nervous system…
Read More...

OvaScienceSM and privately-held Millendo Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases, announced…
Read More...

Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer, announces that it has extended its strategic research collaboration with the Rheumatology Unit…
Read More...